[New pharmaceuticals in treatment of chronic dust bronchitis].
The study was dedicated to the assessment of the therapeutic possibilities provided by erespal (fenspirid) as a new class of pharmaceuticals inhibiting the inflammatory process, in patients with chronic dust bronchitis.
Kosarev
V V
VV
Vakurova
N V
NV
Babanov
S A
SA
D000328:Adult; D001991:Bronchitis / Q000188:drug therapy* / Q000209:etiology*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004391:Dust; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy* / Q000209:etiology*; D016273:Occupational Exposure / Q000009:adverse effects*; D013141:Spiro Compounds / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D004391:Dust; D013141:Spiro Compounds; C084775:fenspiride